Výsledky vyhledávání - "Albert M. Bernath"

Phase II Interventional Study (N0337) of Capecitabine in Combination With Vinorelbine and Trastuzumab for First- or Second-Line Treatment of HER2-Positive Metastatic Breast Cancer: A North Central Cancer Treatment Group Trial

Autor: Patrick J. Flynn, Tom R. Fitch, Muhammad Salim, Edith A. Perez, Winston Tan, Albert M. Bernath, Philip J. Stella, Jacob B. Allred, Martin Wiesenfeld, Paul A. S. Fishkin

Publikováno v: Clinical Breast Cancer. 12:81-86

Background We conducted a multiinstitutional phase II study of capecitabine in combination with vinorelbine and trastuzumab in patients eligible to receive first- or second-line treatment for human epidermal growth factor receptor type 2 (HER2)-posit

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::929887b12cfb8cc42499c0a5a7fdfc72
https://doi.org/10.1016/j.clbc.2012.01.001

Zobrazit plný text záznamu

N0332 phase 2 trial of weekly irinotecan hydrochloride and docetaxel in refractory metastatic breast cancer: a North Central Cancer Treatment Group (NCCTG) Trial

Autor: E. A. Perez, S. S. Gamini, P. J. Stella, Donald W. Northfelt, D. M. Anderson, Muhammad Salim, Frances M. Palmieri, David W. Hillman, R. D. Niedringhaus, Albert M. Bernath, Winston Tan

Publikováno v: Annals of Oncology. 21:493-497

Background Because of the single-agent activity of irinotecan hydrochloride, combination of irinotecan and docetaxel treatment against metastatic breast cancer (MBC) should be evaluated. Patients and methods Single-stage phase 2 study of irinotecan a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f90063a3a2fb14e5802f3f0399dea54
https://doi.org/10.1093/annonc/mdp328

Zobrazit plný text záznamu

Nicotine patch vs. nicotine lozenge for smoking cessation: An effectiveness trial coordinated by the Community Clinical Oncology Program

Autor: Daron G. Ferris, Kristina L. Tatum, Elisa Martinez, Patrick Reynolds, Albert M. Bernath, Marcella Glass, Robert A. Schnoll

Publikováno v: Drug and Alcohol Dependence. 107:237-243

Background Nicotine replacement therapies are efficacious for treating nicotine dependence. However, limited data exist on benefits of different NRTs and predictors of treatment outcome. This study compared the effectiveness of transdermal nicotine v

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::11978170e6d84d6365d4b6884f0b564c
https://doi.org/10.1016/j.drugalcdep.2009.11.001

Zobrazit plný text záznamu

Randomized Controlled Trial to Evaluate Transdermal Testosterone in Female Cancer Survivors With Decreased Libido; North Central Cancer Treatment Group Protocol N02C3

Autor: Wanda L. DeKrey, Pamela J. Atherton, Charles L. Loprinzi, Donald B. Wender, Tim Larson, Paul C. Carpenter, Jeff A. Sloan, Debra L. Barton, Robert J. Dalton, James D. Bearden, Ernie P. Balcueva, Albert M. Bernath

Publikováno v: JNCI Journal of the National Cancer Institute. 99:672-679

BACKGROUND Decreased libido is one of several changes in sexual function that are often experienced by female cancer patients. Transdermal testosterone therapy has been associated with increased libido among estrogen-replete women who report low libi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6cb00f822883a4694a852267fc2d65ae
https://doi.org/10.1093/jnci/djk149

Zobrazit plný text záznamu

Randomized Comparison of a Nicotine Inhaler and Bupropion for Smoking Cessation and Relapse Prevention

Autor: Nguyet A. Le-Lindqwister, Richard D. Hurt, Gary A. Croghan, Charles L. Loprinzi, Stewart C. Garneau, Albert M. Bernath, Donald B. Wender, Shaker R. Dakhil, Kathleen A. Flynn, Kendrith M. Rowland, Paul J. Novotny, Jeff A. Sloan, Loren K. Tschetter, Ivana T. Croghan, Mary L. Loots, Larry P. Ebbert

Publikováno v: Mayo Clinic Proceedings. 82:186-195

To compare the combination of a nicotine inhaler and bupropion to either treatment alone for initiating smoking abstinence and relapse prevention.Smokers were randomized to receive a nicotine inhaler, bupropion, or both for 3 months. At 3 months, smo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f1b7f53a910670eead24bf00109b945
https://doi.org/10.1016/s0025-6196(11)60997-x

Zobrazit plný text záznamu

The prevalence of weight concerns in a smoking abstinence clinical trial

Autor: Philip J. Stella, Paul J. Novotny, Jeff A. Sloan, Albert M. Bernath, Loren K. Tschetter, Gary A. Croghan, Sachdex P. Thomas, Matthew M. Clark, Stewart C. Garneau, Ivana T. Croghan, Larry P. Ebbert, Christi A. Patten, Donald B. Wender, Edward J. Wos, Shaker R. Dakhil, Roscoe F. Morton, Richard D. Hurt, Charles L. Loprinzi, Kendrith M. Rowland

Publikováno v: Addictive Behaviors. 31:1144-1152

Recent research has demonstrated there is a high prevalence of weight concerns in smokers and that smokers with weight concerns may respond poorly to treatment for tobacco dependence. Most studies have focused only on females or have consisted of sma

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::13f758dd06ccb535f018579bb79025b1
https://doi.org/10.1016/j.addbeh.2005.08.011

Zobrazit plný text záznamu

Phase II NCCTG Trial of Oral Topotecan and Paclitaxel With G-CSF (Filgrastim) Support in Patients With Previously Untreated Extensive-Stage Small Cell Lung Cancer

Autor: James R. Jett, Shauna Hillman, Daniel A. Nikcevich, B. S. Lair, Henry D. Tazelaar, Julian R. Molina, James A. Mailliard, Nathan R. Foster, Thomas J. Carroll, Albert M. Bernath

Publikováno v: American Journal of Clinical Oncology. 29:246-251

Objective To determine the efficacy and toxicity of oral topotecan and paclitaxel in untreated patients with extensive stage small cell lung cancer (SCLC). Patients and methods Thirty-eight patients received 1.75 mg/m2 of oral topotecan days 1 to 5 a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e19f2fc33d93d8e6be7340d0a6153858
https://doi.org/10.1097/01.coc.0000217566.11742.b5

Zobrazit plný text záznamu

Phase II trial of oral vinorelbine for the treatment of metastatic breast cancer in patients ≥65 years of age: an NCCTG study

Autor: James A. Mailliard, Tom R. Fitch, Albert M. Bernath, Edith A. Perez, Judith S. Kaur, Vera J. Suman, Steven R. Alberts, Mansoina Baweja, Kendrith M. Rowland

Publikováno v: Annals of Oncology. 17:623-629

Background: A one-stage phase II trial was conducted to assess the tumor response rate and toxicity profile of single agent oral vinorelbine as first or second-line chemotherapy for women at least 65 years of age with metastatic breast cancer. Patien

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b6debaad84b9a9b6f3cb97329f40353
https://doi.org/10.1093/annonc/mdj130

Zobrazit plný text záznamu

Breast Cancer in Elderly Women: Outcome as Affected by Age, Tumor Features, Comorbidities, and Treatment Approach

Autor: Vivek Khandelwal, Albert M. Bernath, Nava Siegelmann-Danieli, Jeffrey W. Prichard, Timothy J. Murphy, G. Craig Wood, Roshan Mainali, James F. Evans, Omar Yumen

Publikováno v: Clinical Breast Cancer. 7:59-66

The current work assessed the independent contributions of age, comorbidities, tumor features, and treatment approach to the outcome of elderly patients with breast cancer.Records of consecutive women agedor = 70 years with a histologic diagnosis of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::564c87cfffb0ca34d9d8e0cb5145e217
https://doi.org/10.3816/cbc.2006.n.014

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání